Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Alexza Pharmaceuticals
Alexza Pharmaceuticals
(ALXA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Adasuve
Loxapine
2012-12-21
2024-2026
Schizophrenia
,
Psychotic disorders
,
Bipolar disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loxapine
psychomotor agitation
Benzodiazepine
healthy volunteers/patients
,
neoplasms
,
gastrointestinal stromal tumors
Tozadenant
renal cell carcinoma
,
prostatic neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
melanoma
,
large b-cell lymphoma diffuse
Antineoplaston a10
healthy volunteers/patients
,
malnutrition
,
pain
,
allergic rhinitis perennial
Histone-arginine methyltransferase carm1
hypopituitarism
,
neurogenic diabetes insipidus
,
depression
,
anxiety disorders
Trinessa
erectile dysfunction
,
torsades de pointes
Surlorian
psoriasis
,
small cell lung carcinoma
Fluoroquinolone
rheumatoid arthritis
,
healthy volunteers/patients
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
pneumonia
,
infections
,
prostatitis
,
pulmonary tuberculosis
,
prostatic neoplasms
,
neutropenia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use